Definition of orphan drug by the EMA
Tuesday March 28th 2023 from 12:30 to 13:30 CET Speaker: [...]
Tuesday March 28th 2023 from 12:30 to 13:30 CET Speaker: [...]
1st part: Tuesday February 7th 2023 from 16:00 to 17:00 [...]
Tuesday February 28th 2023 from 12:00 to 13:00 CET Speakers: Viviana [...]
Post-authorisation safety study of burosumab use in paediatric, adolescent and [...]
Optimising the diagnosis and referral of achondroplasia in Europe: European [...]
More severe phenotype of early-onset osteoporosis associated with recessive form [...]
WNT11, a new gene associated with early onset osteoporosis, is [...]
Skeletal and extraskeletal disorders of biomineralization Collins MT et al., [...]
Clinical, Immunological, and Genetic Findings in a Cohort of Patients [...]
Secondary peripheral chondrosarcoma arising in solitary osteochondroma: variables influencing prognosis [...]
ERN-BOND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are Funded by the European Commission. For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
Funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and
is its sole responsibility; and do not necessarily reflect the opinion of the European Union
Co-funded by the European Union
ERN BOND Specific Grant Agreement no. 101157116
Coordinating Center
Istituto Ortopedico Rizzoli
via G.C.Pupilli, 1 – 40136 Bologna – Italy
The contents of this website represents the views of the network and is its sole responsibility; and do not necessarily reflect the opinion of the European Union